Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 4

  • Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections

    M. N. Prichard

    págs. 1336-1341

    

  • Contribution of rpoB2 RNA Polymerase beta Subunit Gene to Rifampin Resistance in Nocardia Species

    J. Ishikawa

    págs. 1342-1346

    

  • Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa

    P. Nordmann, D. Hockova, F. El Garch

    págs. 1347-1351

    

  • Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies

    D. Tasdemir

    págs. 1352-1364

    

  • Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans

    D. Hiller, J. Morschhauser, D. Sanglard

    págs. 1365-1371

    

  • Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery

    K. Skhirtladze

    págs. 1372-1375

    

  • Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of an In Vivo Pharmacokinetic-Pharmacodynamic Target

    W. A. Craig, D. Andes

    págs. 1376-1383

    

  • Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants

    J. E. Bennett, K. E. Sarti, A. A. Krol, H. F. Tsai

    págs. 1384-1392

    

  • Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation

    A. Vaillant, C. Lackman Smith, J.-M. Juteau

    págs. 1393-1401

    

  • Protease-Stable Polycationic Photosensitizer Conjugates between Polyethyleneimine and Chlorin(e6) for Broad-Spectrum Antimicrobial Photoinactivation

    G. P. Tegos

    págs. 1402-1410

    

  • Comparative Analysis of Chromosome-Encoded Microcins

    M. F. Azpiroz, M. E. Pocy

    págs. 1411-1418

    

  • Efficacy of Hospital Germicides against Adenovirus 8, a Common Cause of Epidemic Keratoconjunctivitis in Health Care Facilities

    J. E. Peacock, W. A. Rutala

    págs. 1419-1424

    

  • Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli

    V. Ramachandran, B. Chandrakala

    págs. 1425-1432

    

  • Human beta-Defensin 2 Induces a Vigorous Cytokine Response in Peripheral Blood Mononuclear Cells

    M. Boniotto, W. J. Jordan

    págs. 1433-1441

    

  • Genetic Structures at the Origin of Acquisition and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene bla~O~X~A~-~5~8 in Acinetobacter baumannii

    P. Nordmann, L. Poirel

    págs. 1442-1448

    

  • Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies

    R. R. Bonelli, T. Schneider

    págs. 1449-1457

    

  • Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center

    K. S. Long, L. H. Hansen

    págs. 1458-1462

    

  • Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility

    M. A. Jabra-Rizk

    págs. 1463-1469

    

  • Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

    L. M. Aschenbrenner, M. P. Malakhov

    págs. 1470-1479

    

  • Adding Selectivity to Antimicrobial Peptides: Rational Design of a Multidomain Peptide against Pseudomonas spp

    R. Eckert

    págs. 1480-1488

    

  • Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNA

    S. N. Hobbie

    págs. 1489-1496

    

  • Preclinical Evaluation of Synthetic -2 RANTES as a Candidate Vaginal Microbicide To Target CCR5

    T. M. Kish Catalone

    págs. 1497-1509

    

  • Multidimensional Volumetric Imaging of Pulmonary Infiltrates for Measuring Therapeutic Response to Antifungal Therapy in Experimental Invasive Pulmonary Aspergillosis

    R. Petraitiene, V. Petraitis

    págs. 1510-1517

    

  • Substrate Envelope and Drug Resistance: Crystal Structure of RO1 in Complex with Wild-Type Human Immunodeficiency Virus Type 1 Protease

    M. Prabu Jeyabalan

    págs. 1518-1521

    

  • The Antimicrobial Peptide Polyphemusin Localizes to the Cytoplasm of Escherichia coli following Treatment

    J. P. S. Powers

    págs. 1522-1524

    

  • In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum beta-Lactamase

    L. Poirel, J. D. D. Pitout

    págs. 1525-1527

    

  • Microflora Changes with Norfloxacin and Pivmecillinam in Women with Recurrent Urinary Tract Infection

    B. S. Norinder

    págs. 1528-1530

    

  • Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-Amodiaquine

    P. Agnamey, P. Brasseur, P. E. de Pecoulas

    págs. 1531-1534

    

  • Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon

    A. Kreidenweiss

    págs. 1535-1537

    

  • Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in Japan

    T. Nishizawa

    págs. 1538-1540